The pharma industrys biggest trade group boosted revenue by nearly a fourth last year and spread the millions collected among hundreds of lobbyists, politicians and patient groups.
Here are five things we learned in 2017 that can help employers turn the cost challenge into an opportunity to better manage expenses in 2018 and beyond.
As polls showed growing disapproval among Americans of the tax bill, the House voted in favor of it, and the final GOP tax bill now moves to the Senate for a vote.
As insurers wait to see the vote outcome on the Republican tax bill, and its provision for the repeal of the individual mandate of the Affordable Care Act, theyre already trying to calculate the rate at which theyll have to raise premiums to keep themselves solvent
As the nations bill for drug and genetic tests has climbed to an estimated $8.5 billion a year, theres mounting suspicion among health insurers that some testing may do more to boost profit margins than help treat patients.
For months now, pharmacy and health benefits companies have fretted that theyre the next targets of Jeff Bezoss disruption steamroller, but Amazon hasnt yet figured out how to shake up a notoriously complex business.
Our guests lay out how the government, Big Pharma, hospital systems, and health insurance companies are incentivized to stop price deflation and maintain complexity.